Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Shorter Telomeres Linked to Dangerous Blood Cell Mutations
September 2025
A major UK-based study has revealed a new link between ageing, DNA changes and the development of blood cancers….
Read more
22 May 2025
COMy 2025: Diagnosis Delays in Amyloid Light-Chain Amyloidosis
Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.
20 May 2025
Genetic Screening Reduces Severe Thalassaemia Cases
A large-scale study involving over 28,000 women has demonstrated the effectiveness of next-generation sequencing (NGS) in identifying thalassemia carriers and preventing severe cases of the genetic blood disorder…
18 May 2025
Blood Test Offers Breakthrough in Heart Disease Treatment
A groundbreaking study has introduced a novel, image-based blood test that could significantly enhance the way doctors manage and personalise treatment for coronary artery disease (CAD), a leading global cause of death.
14 May 2025
Armoured CAR T-Cell Therapy Shows Promise in Resistant Lymphoma
A novel form of CAR T-cell therapy, engineered to enhance immune response, is showing encouraging results in patients with relapsed or refractory lymphoma who previously failed anti-CD19 CAR T-cell treatment.
8 May 2025
Menstrual Cycle May Influence Inflammation in Women with Sickle Cell Disease
A recent study has found that women with sickle cell disease experience higher inflammation during the follicular phase of their menstrual cycle, which may explain the timing of pain episodes and offer insight into more personalised care.
7 May 2025
New Treatment Strategy May Boost Survival in T-Cell Lymphomas
A retrospective analysis of global data has found that a specific treatment sequence, starting with small molecule inhibitors and followed by epigenetic modifiers, may significantly improve survival in patients with relapsed or refractory T-cell lymphomas.
5 May 2025
New Castleman Disease Subtype Identified
A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….
4 May 2025
New Blood Test Shows Promise in Predicting Melanoma Recurrence Risk
A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.
Loading posts...
« Previous
1
…
4
5
6
7
8
…
39
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View